rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2011-4-7
|
pubmed:abstractText |
With the introduction of the ViroSeq™ HIV-1 Genotyping System (ViroSeq™ assay) into China, it is important to evaluate the impact of the diversity of HIV-1 genotypes found in China on the performance of the ViroSeq™ assay compared with an in-house method.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1177-1062
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-52
|
pubmed:meshHeading |
pubmed-meshheading:21469769-Anti-Retroviral Agents,
pubmed-meshheading:21469769-China,
pubmed-meshheading:21469769-Drug Resistance, Viral,
pubmed-meshheading:21469769-Genotype,
pubmed-meshheading:21469769-HIV Infections,
pubmed-meshheading:21469769-HIV-1,
pubmed-meshheading:21469769-Humans,
pubmed-meshheading:21469769-Mutation,
pubmed-meshheading:21469769-Protease Inhibitors,
pubmed-meshheading:21469769-Reverse Transcriptase Inhibitors,
pubmed-meshheading:21469769-Sequence Analysis, RNA,
pubmed-meshheading:21469769-pol Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2011
|
pubmed:articleTitle |
Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
|
pubmed:affiliation |
Department of Cell Biology, National Institute for the Control of Pharmaceutical and Biological Products, Beijing, PR China.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|